Patents by Inventor Arthur A. Patchett

Arthur A. Patchett has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 4431821
    Abstract: Novel 1-fluoromethyl-substituted alkyl amines are disclosed. The novel compounds have biological activity including decarboxylase inhibition.
    Type: Grant
    Filed: July 20, 1981
    Date of Patent: February 14, 1984
    Assignee: Merck & Co., Inc.
    Inventors: Arthur A. Patchett, Janos Kollonitsch
  • Patent number: 4423063
    Abstract: 2,4-Dioxo-4-substituted-1-butanoic acid derivatives of the formula: ##STR1## where R is hydrogen or C.sub.1-4 alkyl; andL is a lipophilic group consisting essentially of ##STR2## where R' is (a) hydrogen; (b) C.sub.1-3 alkyl; (c) benzyl; (d) pyridyl C.sub.1-3 alkyl or (e) (3,4-dihydro-3-hydroxy-2H-1,5-benzodioxepin-3-yl) methyl; provided that positions 2 and 6 of the substituted phenyl moiety may not be substituted; or ##STR3## where R' has the same meaning as above; or a pharmaceutically acceptable salt thereof; useful in treating urinary tract, especially renal calcium oxalate lithiasis.
    Type: Grant
    Filed: March 5, 1982
    Date of Patent: December 27, 1983
    Assignee: Merck & Co., Inc.
    Inventors: Clarence S. Rooney, Haydn W. R. Williams, Edward J. Gragoe, Jr., Arthur A. Patchett
  • Patent number: 4415496
    Abstract: The invention relates to bicyclic lactams and related compounds which are useful as antihypertensives.
    Type: Grant
    Filed: February 19, 1982
    Date of Patent: November 15, 1983
    Assignee: Merck & Co., Inc.
    Inventors: Elbert E. Harris, Arthur A. Patchett, Edward W. Tristram, Eugene D. Thorsett, Matthew J. Wyvratt, Jr.
  • Patent number: 4402969
    Abstract: The invention relates to urea compounds which are useful as antihypertensives.
    Type: Grant
    Filed: January 21, 1982
    Date of Patent: September 6, 1983
    Assignee: Merck & Co., Inc.
    Inventors: William J. Greenlee, David G. Hangauer, Jr., Arthur A. Patchett
  • Patent number: 4401676
    Abstract: Novel .alpha.-ethynyl- and .alpha.-vinyl 3,4-disubstituted phenylalanines are disclosed. The compounds have pharmaceutical activity.
    Type: Grant
    Filed: June 1, 1977
    Date of Patent: August 30, 1983
    Assignee: Merck & Co., Inc.
    Inventors: Arthur A. Patchett, David Taub
  • Patent number: 4379146
    Abstract: There are disclosed substituted phosphonamides and related compounds which are useful as converting enzyme inhibitors and as antihypertensives.
    Type: Grant
    Filed: November 5, 1981
    Date of Patent: April 5, 1983
    Assignee: Merck & Co., Inc.
    Inventors: William J. Greenlee, Elbert E. Harris, Arthur A. Patchett, Eugene D. Thorsett
  • Patent number: 4374829
    Abstract: The invention relates to new carboxyalkyl dipeptide derivatives and related compounds which are useful as antihypertensives.
    Type: Grant
    Filed: February 17, 1981
    Date of Patent: February 22, 1983
    Assignee: Merck & Co., Inc.
    Inventors: Elbert E. Harris, Arthur A. Patchett, Edward W. Tristram, Matthew J. Wyvratt
  • Patent number: 4360533
    Abstract: Glyceryl esters of 1-methyl-2-(3,4-dihydroxyphenyl)alanine, pharmaceutical compositions and method of treatment are disclosed.
    Type: Grant
    Filed: December 14, 1981
    Date of Patent: November 23, 1982
    Assignee: Merck & Co., Inc.
    Inventor: Arthur A. Patchett
  • Patent number: 4351844
    Abstract: Hydrogenation of the natural fermentation product, mevinolin, MK-803, results in the production of dihydro- and tetra-hydro derivatives and hydrogenation of the naturally occurring dihydromevinolin results in the formation of a tetrahydro derivative. These several products with the exception of cis-(4.alpha..beta., 8.alpha..beta.-)-tetrahydromevinolin are potent inhibitors of cholesterol biosynthesis.
    Type: Grant
    Filed: December 1, 1980
    Date of Patent: September 28, 1982
    Assignee: Merck & Co., Inc.
    Inventors: Arthur A. Patchett, Chan-Hwa Kuo
  • Patent number: 4347375
    Abstract: A process for preparing .alpha.-amino acids or ester thereof having an .alpha.-vinyl substituent and certain intermediates are disclosed.
    Type: Grant
    Filed: December 3, 1980
    Date of Patent: August 31, 1982
    Assignee: Merck & Co., Inc.
    Inventors: Arthur A. Patchett, William J. Greenlee
  • Patent number: 4339453
    Abstract: 4-Amino- and 2,4-diaminopyrimidines with a quaternized ring nitrogen and an oxygen bearing substituent such as hydroxyalkyl, alkoxyalkyl, or alkanoyl on one of the exo- or endocyclic nitrogens and a C.sub.6-18 alkyl on another, are highly active antimicrobial agents with a relatively low acute mammalian toxicity.
    Type: Grant
    Filed: July 23, 1979
    Date of Patent: July 13, 1982
    Assignee: Merck & Co., Inc.
    Inventors: Nathaniel Grier, Elbert E. Harris, Henry Joshua, Arthur A. Patchett, Bruce E. Witzel, Richard A. Dybas
  • Patent number: 4337258
    Abstract: 2,4-Dioxo-4-substituted-1-butanoic acid derivatives of the formula: ##STR1## where R is hydrogen or C.sub.1-4 alkyl; andL is a lipophilic group consisting essentially of(1) ##STR2## where R' is (a) hydrogen; (b) C.sub.1-3 alkyl; (c) benzyl; (d) pyridyl C.sub.1-3 alkyl; or (e) (3,4-dihydro-3-hydroxy-2H-1,5-benzodioxepin-3-yl) methyl; provided that positions 2 and 6 of the substituted phenyl moiety may not be substituted; or(2) ##STR3## where R' has the same meaning as above; or a pharmaceutically acceptable salt thereof; useful in treating urinary tract, especially renal calcium oxalate lithiasis.
    Type: Grant
    Filed: December 29, 1980
    Date of Patent: June 29, 1982
    Assignee: Merck & Co., Inc.
    Inventors: Clarence S. Rooney, Haydn W. R. Williams, Edward J. Cragoe, Jr., Arthur A. Patchett
  • Patent number: 4336397
    Abstract: 2,4-Dioxo-4-substituted-1-butanoic acid derivatives of the formula: ##STR1## where R is hydrogen or C.sub.1-4 alkyl; andL is a lipophilic group consisting essentially of: ##STR2## where R.sup.1 and R.sup.2 are each independently selected from the group consisting of (a) hydrogen; (b) C.sub.4-12 straight or branched chain alkyl; (c) C.sub.4-7 cycloalkyl; and (d) tetrahydronaphthyl; provided that R.sup.1 and R.sup.2 may not both be hydrogen; and when one of R.sup.1 or R.sup.2 is tetrahydronaphthyl, the other must be some other substituent; and that positions 2 and 6 of the substituted phenyl moiety may not be substituted; and ##STR3## where R.sup.1, and R.sup.2 have the same meaning as above except tetrahydronaphthyl;R.sup.3 is bromine, chlorine, or fluorine;m is 0 to 3;or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: December 29, 1980
    Date of Patent: June 22, 1982
    Assignee: Merck & Co., Inc.
    Inventors: Edward J. Cragoe, Jr., Arthur A. Patchett, Clarence S. Rooney, Haydn W. R. Williams
  • Patent number: 4325961
    Abstract: Novel substituted .alpha.-fluoromethyl-.alpha.-amino alkanoic acids and esters thereof are disclosed. The novel compounds have biological activity including decarboxylase inhibition.
    Type: Grant
    Filed: June 1, 1977
    Date of Patent: April 20, 1982
    Assignee: Merck & Co., Inc.
    Inventors: Janos Kollonitsch, Arthur A. Patchett
  • Patent number: 4316896
    Abstract: The invention relates to new phosphoryl aminoacid derivatives and related compounds which are useful as antihypertensives.
    Type: Grant
    Filed: September 7, 1978
    Date of Patent: February 23, 1982
    Assignee: Merck & Co., Inc.
    Inventors: Eugene D. Thorsett, Arthur A. Patchett, Elbert E. Harris, Alan L. Maycock
  • Patent number: 4275220
    Abstract: A process for preparing .alpha.-amino acids or ester thereof having an .alpha.-vinyl substituent and certain intermediates are disclosed.
    Type: Grant
    Filed: August 6, 1979
    Date of Patent: June 23, 1981
    Assignee: Merck & Co., Inc.
    Inventors: Arthur A. Patchett, William J. Greenlee
  • Patent number: 4070360
    Abstract: A new heterocycle, 5,11-diazatetracyclo-[6.2.2.0.sup.2,7.0.sup.4,9 ]dodecane, is prepared by heating an endo-diazatricyclo[6.2.2.0.sup.2,7 ]dodec-11-ene substituted in the 7 and 11 positions with electron withdrawing groups. 2,9-Bis-phenylacetyl derivatives of the new heterocycle and closely related derivatives are potent analgesic agents.
    Type: Grant
    Filed: March 24, 1977
    Date of Patent: January 24, 1978
    Assignee: Merck & Co., Inc.
    Inventors: Jan ten Broeke, Edward J. J. Grabowski, Lars M. Flataker, Michael H. Fisher, Arthur A. Patchett
  • Patent number: 4070359
    Abstract: A new heterocycle, 5,11-diazatetracyclo]6.2.2.0.sup.2,7.0.sup.4,9 ]dodecane, is prepared by heating an endo-diazatricyclo[6.2.2.0.sup.2,7 ]dodec-11-ene substituted in the 7 and 11 positions with electron withdrawing groups. 2,9-Bis-phenylacetyl derivatives of the new heterocycle and closely related derivatives are potent analgesic agents.
    Type: Grant
    Filed: March 24, 1977
    Date of Patent: January 24, 1978
    Assignee: Merck & Co., Inc.
    Inventors: Jan ten Broeke, Edward J. J. Grabowski, Lars M. Flataker, Michael H. Fisher, Arthur A. Patchett
  • Patent number: 4033968
    Abstract: A new heterocycle, 5,11-diazatetracyclo[6.2.2.0.sup.2,7.0.sup.4.9 ]dodecane, is prepared by heating an endo-diazatricyclo[6.2.2.0.sup.2,7 ]dodec-11-ene substituted in the 7 and 11 positions with electron withdrawing groups. 2,9-Bis-phenylacetyl derivatives of the new heterocycle and closely related derivatives are potent analgesic agents.
    Type: Grant
    Filed: April 14, 1976
    Date of Patent: July 5, 1977
    Assignee: Merck & Co., Inc.
    Inventors: Jan ten Broeke, Edward J. J. Grabowski, Lars M. Flataker, Michael H. Fisher, Arthur A. Patchett
  • Patent number: 3991185
    Abstract: Emimycin, 1,2-dihydro-1-(2-deoxy-.beta.-D-erythropentofuranosyl)-2-oxypyrazine-4-oxi de and the novel compounds 1,2-dihydro-1-(2-deoxy-3,5-di-O-loweralkanoyl-.alpha.-D-erythro-pentofuran osyl)-2-oxopyrazine 4-oxide are active anticoccidial agents. Preferably, the alkanoyl group of the novel compounds contain up to six carbon atoms. The compounds are included in compositions useful for the prevention and treatment of coccidiosis in poultry.
    Type: Grant
    Filed: May 12, 1975
    Date of Patent: November 9, 1976
    Assignee: Merck & Co., Inc.
    Inventors: Arthur A. Patchett, Ching C. Wang